# RTI Health Solutions

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/rti-health-solutions/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 15.4 |
| Citations | 179,560 |
| City | Durham |
| Country | US |
| Description | RTI Health Solutions is a research organisation in Durham, US. OpenAlex records 3,374 works and 179,560 citations for it. 488 researchers list it as their most recent affiliation. |
| Homepage | https://www.rtihs.org/ |
| OpenAlex ID | https://openalex.org/I4210120329 |
| Region | North Carolina |
| Researchers | 488 |
| ROR ID | https://ror.org/032nh7f71 |
| Type | nonprofit |
| Works | 3,374 |

## University papers

Showing 12 of 38.

- [Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force](https://scholariq.org/papers/consolidated-health-economic-evaluation-reporting-standards-cheers-explanation/)
- [Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force](https://scholariq.org/papers/conjoint-analysis-applications-in-health-a-checklist-a-report-of-the-ispor-good/)
- [Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement](https://scholariq.org/papers/consolidated-health-economic-evaluation-reporting-standards-cheers-statement/)
- [Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations](https://scholariq.org/papers/consolidated-health-economic-evaluation-reporting-standards-2022-cheers-2022/)
- [The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review](https://scholariq.org/papers/the-epidemiology-economic-burden-and-pharmacological-treatment-of-chronic-low/)
- [A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States](https://scholariq.org/papers/a-population-based-study-of-peyronie-s-disease-prevalence-and-treatment-patterns/)
- [The Faces of Personalized Medicine: A Framework for Understanding Its Meaning and Scope](https://scholariq.org/papers/the-faces-of-personalized-medicine-a-framework-for-understanding-its-meaning-and/)
- [Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States](https://scholariq.org/papers/frequency-and-severity-of-vasomotor-symptoms-among-peri-and-postmenopausal-women/)
- [Healthcare seeking and treatment for menopausal symptoms in the United States](https://scholariq.org/papers/healthcare-seeking-and-treatment-for-menopausal-symptoms-in-the-united-states/)
- [Shades of Green: Measuring the value of urban forests in the housing market](https://scholariq.org/papers/shades-of-green-measuring-the-value-of-urban-forests-in-the-housing-market/)
- [Crohn’s Disease Patients’ Risk-Benefit Preferences: Serious Adverse Event Risks Versus Treatment Efficacy](https://scholariq.org/papers/crohn-s-disease-patients-risk-benefit-preferences-serious-adverse-event-risks/)
- [Characterization of early pathogenesis in the <scp>SOD</scp>1<sup>G93A</sup> mouse model of <scp>ALS</scp>: part II, results and discussion](https://scholariq.org/papers/characterization-of-early-pathogenesis-in-the-scp-sod-scp-1-sup-g93a-sup-mouse/)

## University researchers

- [Carol Mansfield](https://scholariq.org/researchers/carol-mansfield/)
- [Dana DiBenedetti](https://scholariq.org/researchers/dana-dibenedetti/)
- [Deirdre Mladsi](https://scholariq.org/researchers/deirdre-mladsi/)
- [K. Kosa](https://scholariq.org/researchers/k-kosa/)
- [L. Zografos](https://scholariq.org/researchers/l-zografos/)
- [D. Wolin](https://scholariq.org/researchers/d-wolin/)

## University top topics

Showing 8 of 25.

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Vaccine Coverage and Hesitancy](https://scholariq.org/topics/vaccine-coverage-and-hesitancy/)
- [Economic and Environmental Valuation](https://scholariq.org/topics/economic-and-environmental-valuation/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Respiratory viral infections research](https://scholariq.org/topics/respiratory-viral-infections-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.